Correction to: Hypofractionated sequential radiotherapy boost: a promising strategy in inoperable locally advanced pancreatic cancer patients (Journal of Cancer Research and Clinical Oncology, (2021), 147, 3, (661-667), 10.1007/s00432-020-03411-7)

Gian Carlo Mattiucci, Luca Boldrini, Alessia Nardangeli, Andrea D’Aviero, Milly Buwenge, Francesco Cellini, Francesco Deodato, Nicola Dinapoli, Vincenzo Frascino, Gabriella Macchia, Alessio Giuseppe Morganti, Vincenzo Valentini

Research output: Contribution to journalArticle

Abstract

In the original article published, the last sentence in the sixth paragraph of the introduction section is incorrect. The correct sentence is “This data, were confirmed also in an Italian phase II study, in which it has been demonstrated that gemcitabine-based chemoradiotherapy was correlated with improved overall survival, especially in pts who are clinically more fit to complete the foreseen treatment schedule (CRT) (Mattiucci et al. 2010)”. The original article has been corrected.
Original languageEnglish
Pages (from-to)669-669
Number of pages1
JournalJournal of Cancer Research and Clinical Oncology
Volume147
DOIs
Publication statusPublished - 2021

Keywords

  • n/a

Fingerprint

Dive into the research topics of 'Correction to: Hypofractionated sequential radiotherapy boost: a promising strategy in inoperable locally advanced pancreatic cancer patients (Journal of Cancer Research and Clinical Oncology, (2021), 147, 3, (661-667), 10.1007/s00432-020-03411-7)'. Together they form a unique fingerprint.

Cite this